User: Guest  Login
Document type:
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Article 
Author(s):
Schulz, Stefanie; Richardt, Gert; Laugwitz, Karl-Ludwig; Mehran, Roxana; Gershlick, Anthony H; Morath, Tanja; Mayer, Katharina; Neudecker, Julia; Tölg, Ralph; Ibrahim, Tareq; Hauschke, Dieter; Braun, Daniel; Schunkert, Heribert; Kastrati, Adnan; Mehilli, Julinda 
Title:
Comparison of prasugrel and bivalirudin vs clopidogrel and heparin in patients with ST-segment elevation myocardial infarction: Design and rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 trial. 
Abstract:
Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for patients with ST-segment elevation myocardial infarction (STEMI). Effective and safe adjunct antithrombotic therapy is a major determinant for short- and long-term outcomes after primary PCI. Two separate studies have shown significant benefits vs conventional therapy for 2 recently approved drugs. In the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) t...    »
 
Journal title abbreviation:
Clin Cardiol 
Year:
2014 
Journal volume:
37 
Journal issue:
Pages contribution:
270-6 
Language:
eng 
Fulltext / DOI:
Print-ISSN:
0160-9289 
TUM Institution:
I. Medizinische Klinik und Poliklinik (Kardiologie); Klinik für Herz- und Kreislauferkrankungen im Erwachsenenalter (Prof. Schunkert)